Published Date: 26 Apr 2023
Once a woman turns 40, experts advise that she at the very least think about starting a breast cancer screening program. According to a recent study, Black women need this advice above all others.
Read Full NewsHere's some of what is coming soon to NeurologyLive® this week.
Allison B. Reiss, MD, associate professor of medicine at NYU Grossman Long Island School of Medicine discussed the often-overlooked early signs of early-onset Alzheimer disease.
Gefurulimab (Klygefa), a once-weekly, self-administered complement C5 inhibitor from Alexion and AstraZeneca, is now approved in the US for adults with AChR-antibody-positive generalized myasthenia gravis.
A new FDA filing seeks to expand cenobamate's epilepsy indication to primary generalized tonic-clonic seizures, based on positive phase 3 trial data.
The professor of neurology at UT Southwestern Medical Center discussed emerging trials, proposed changes to myelitis diagnostic criteria and nomenclature, and the unmet needs raised by patients at this year’s symposium.
A new global phase 2 trial, TARBELA-AD, will test RG6434, Roche's investigational oral NLRP3 inflammasome inhibitor, in adults with early symptomatic Alzheimer disease.
A pivotal phase 2/3 trial of Zhimeng Biopharma's CB03-154, an oral KCNQ2/3 potassium channel opener, has completed enrollment in amyotrophic lateral sclerosis.
1.
Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC
2.
Radioactive ion beams successfully treat animal tumors in study
3.
PSA Screening Overdiagnosis Rises Sharply With Age
4.
FDA Advisors Split on Regimens for Breast, Prostate Cancers
5.
Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models
1.
Oncology Team Communication Training for Clinical Learners
2.
Uncovering the Mysteries of Breast Cancer: The Journey to a Cure
3.
Minimal Residual Disease Monitoring: Advances, Clinical Relevance, and Guideline-Based Perspectives
4.
Prevention of Thrombotic Complications in High-Risk Patients
5.
Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
Early Signs of Cancer: Importance of Early Detection
3.
Immunotherapy: A New Era in Cancer Treatment
4.
How Advances in Cancer Research Are Improving Treatment Options
5.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation